Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care

Journal of Hypertension

Volumn 22, Issue 1, 2004, Pages 51-57

  Mancia, Giuseppe ^a,e   Volpe, Roberta ^b   Boros, Stefano ^c   Ilardi, Maura ^d   Giannattasio, Cristina ^a  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b CNR   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d GSK   (Italy)

^e SAN GERARDO HOSPITAL   (Italy)

Author keywords

Cardiovascular risk profile; Essential hypertension; Metabolic risk factors; Treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; ETHNIC GROUP; FEMALE; HEALTH CARE ORGANIZATION; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MEDICAL SPECIALIST; OBESITY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WORLD HEALTH ORGANIZATION;

EID: 1442299102     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200401000-00012     Document Type: Article

References (27)

1. Kannel WB. Cardioprotection and antihypertensive therapy: the key importance of addressing the associated coronary risk factors (the Framingham experience). Am J Cardiol 1996; 77:6B-11B.
2. Menotti A, Lanti M, Zanchetti A, Puddu PE, Cirillo M, Mancini M, Vagnarelli OT. Impact of the GUBBIO population study on community control of blood pressure and hypertension. Gubbio Study research group. J Hypertens 2001; 19:843-850.
3. Sawers JR, Ebstein M. Diabetes mellitus and associated hypertension, vascular disease and nephropathy, an update. Hypertension 1995; 26:869-879.
4. Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular and all-cause mortality and to longevity. JAMA 2002; 284:311-318.
5. Ford ES, Giles WH, Dietz WH, Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287:356-359.
6. Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157:2413-2446.
7. WHO/ISH (Guidelines Subcommittee). 1999 World Health Organization- International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17:151-183.
8. EUROASPIRE Study Group. A European Society of cardiology survey of secondary prevention of coronary heart disease: Principal results. Eur Heart J 1997; 18:1569-1582.
9. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II. Eur Heart J 2001; 22:554-572.
10. Mancia G, Grassi G. Rationale for the use of a fixed combination in the treatment of hypertension. Eur Heart J 1999; 1:L14-L19.
11. Benetos A, Thomas F, Bean K, Gautier S, Smulyan H, Guize L. Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch Intern Med 2002; 162:577-581.
12. Mancia G, Sega R, Milesi C, Cesana GC, Zanchetti A. Blood pressure control in the hypertensive population. Lancet 1997; 349:454-457.
13. Mancia G, Bombelli M, Lanzarotti A, Grassi G, Cesana G, Zanchetti A, Sega R. Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. Arch Intern Med 2002; 162:582-586.
14. Agabiti-Rosei E, Giovannini E, Mancia G, Novo S, Pede S, Rappelli A, et al. Arterial hypertension and cardiac pathology. Diagnostic and therapeutic guidelines presented by the Joint Commission of the ANMCO-SIC-SIIA. Associazione Nazionale Medici Cardiologi Ospedalieri. Societá Italiana di cardiologia. Societá Italiana dell'Ipertensione Arteriosa. G Ital Cardiol 1999; 29:341-356.
15. Giampaoli S, Vannuzzo D and the Research Group of the Cardiovascular Epidemiological Observatory. Cardiovascular risk factors in Italy: an interpretation with reference to the national Health Plan 1998-2000. G Ital Cardiol 1999; 29:1463-1471.
16. Swales JD. Current clinical practice in hypertension: the EISBERG (Evaluation and Interventions for Systolic Blood Pressure Elevation - Regional and Global) project. Am Heart J 1999; 138:S231-S237.
17. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25:305-313.
18. Mallion JM, Schmitt D. Patient compliance in the treatment of arterial hypertension. Blood Press 2002; 11:253-254.
19. Mancia G, Grassi G. Systolic and diastolic blood pressure control in hypertensive drug trials. J Hypertens 2002; 20:1461-1464.
20. Collado-Mesa F, Colhoun HM, Stevens LK, Boavida J, Ferriss JB, Karamanos B, et al. Prevalence and management of hypertension in type 1 diabetes mellitus in Europe: The EURODIAB IDDM Complications Study. Diabet Med 1999; 16:41-48.
21. Brown MJ, Castaigne A, DeLeeuw PW, Mancia G, Rosenthal T, Ruilope LM. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT). J Hypertens 1998, 16:2113-2116.
22. Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, De Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359:1004-1010.
23. Lindholm LH, Hansson L, Ekbom T, Dahlof B, Lanke J, Linjer E, et al. Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension-2. STOP Hypertension-2 Study Group. J Hypertens 2000; 18:1671-1675.
24. Hansson L, Hedner T, Lund-Johansen P, Kjeldsen SE, Lindholm LH, Syversten JO, et al. Randomised trial of effects of calium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Lancet 2000; 356:359-365.
25. Hanson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998; 351:1755-1762.
26. Joint European Societies. Recommendations on prevention of coronary heart disease in clinical practice. Atherosclerosis 1998; 140:199-270.
27. Cuspidi C, Ambrosioni E, Mancia G, Pessina AC, Trimarco B, Zanchetti A; on Behalf of the APROS Investigators. Role of echocardiography and caroid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey. J Hypertens 2002; 20:1307-1314.